4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-103162
Chairman & CEO bought 1,500 shares at an average $7.85 ($11,775)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENTSUR RON Chairman & CEO | 2022-09-23 | Purchase | +1,000 | $7.93 | $7,930 | 3,011,609 | D: show line 1 in the form |
| BENTSUR RON Chairman & CEO | 2022-09-26 | Purchase | +500 | $7.69 | $3,845 | 3,012,109 | D: show line 2 in the form |
| Open-market purchases · 1,500 sh · avg $7.85 · $11,775 | |||||||
Loading xslF345X03/tm2226689-1_4seq1.xml…